1
Registered trials
1
Recruiting
1
Unique sponsors
2
Unique IMPs
0
Commercial trials
Drug classes (ATC)
J
Anti-infectives (ATC J)
1
Mechanism of action (INN-stem analysis)
Monoclonal antibody
1 substance
Unknown / small molecule
1 substance
Phase III:
1
Phase III
1 trial-
RecruitingCentre Hospitalier Annecy Genevois AcademicNIRSEVIMAB; RESPIRATORY SYNCYTIAL VIRUS, SUBGROUP A, STABILIZED PREFUSION F PROTEIN 847A, RESPIRATORY SYNCYTIAL VIRUS, SUBGROUP B, STABILIZED PREFUSION F PROTEIN 847B
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| Centre Hospitalier Annecy Genevois | Academic | 1 | Phase III | 1 |
New trials by year
2026
1